Gates Foundation Invests $40 Million to Accelerate mRNA Vaccine Manufacturing in Africa
At the Grand Challenges Annual Meeting in Dakar, Senegal, Gates announced $40 million in new investments to build mRNA vaccine manufacturing capacity in lower-income countries: $20 million to Quantoom Biosciences (Belgium) to develop its low-cost mRNA platform, and $5 million each to Institut Pasteur de Dakar (Senegal) and Biovac (South Africa) to deploy the technology locally. Gates described mRNA technology as a potential 'game-changer' for diseases including tuberculosis, malaria, and Lassa fever. The initiative built on the foundation's prior $55 million BioNTech investment and sought to ensure Africa could manufacture its own mRNA vaccines for future outbreaks.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
R21/Matrix-M malaria vaccine receives first national regulatory approval — in Ghana
Next →
Gates Meets President Xi Jinping; Foundation Pledges $50 Million to Tsinghua Drug Discovery Institute
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
December 2025
Gates Foundation Pledges $100 Million to Global Financing Facility for Women's and Children's Health 2026–2030
On December 6, 2025, at the Universal Health Coverage High-Level Forum in Tokyo, the Gates Foundation pledged $100 million to the World Bank-hosted Global Financing Facility's 2026–2030 strategy for ending preventable deaths among women, children, and adolescents in LMICs. The pledge brings the foundation's total GFF commitment past $500 million since 2015. The GFF provides catalytic grant financing and technical assistance to strengthen LMIC health systems and expand quality access to health and nutrition services for the world's most vulnerable populations.
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.